Alex Dahmani

Director of Business Development • Adaptive Biotechnologies

Alex Dahmani has degrees in Genetics, Immunology, and Business.  His academic research focused on human T cell activity using an advanced humanized mouse model.  Prior to working at Adaptive Biotechnologies, he worked for Columbia Technology Ventures where he helped review and commercialize new technologies invented on campus.  He also started a remote patient monitoring company called Quio Technologies.  At Adaptive, he works with biotech and pharma partners who use Adaptive’s immune medicine platform to discover and develop novel immunotherapies for infectious disease, autoimmunity, and oncology.  

Also Speaking

Mona Jhaveri

Senior Vice President, Technical Operations • Music Beats Cancer

Michael E. Meyers

Managing Director, Head of Investment Banking; Interim Chief Executive Officer, Cell BT • H.C.WainWright&Co

Peter Walters

Fellow, Advanced Therapies • CRB

Also Speaking


Germfree Truck



Book your hotel room for your stay in Miami.